In the most comprehensive study of COVID-19 pediatric patients to date, Massachusetts General Hospital (MGH) and Mass General Hospital for Children (MGHfC) researchers provide critical data showing that children play a larger ...
Aug 20, 2020
0
10140
As the coronavirus pandemic stretches on, a small proportion of Australians infected have now died, while most have either recovered, or are likely to recover over the next few weeks.
Apr 13, 2020
0
32
Pharmaceutical giant Merck and an American laboratory reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients' viral load.
Mar 7, 2021
0
1023
With the successful suppression of the AIDS virus (HIV) through medication, the focus turns toward its eradication. Researchers from Kumamoto University in Japan have developed a new compound that is key to the destruction ...
Oct 2, 2017
0
632
An antibody cocktail being tested at UVA Health and other sites was able to block 100% of symptomatic COVID-19 infections among people exposed to the virus, early results from the clinical trial suggest.
Feb 4, 2021
0
50
A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.
Jul 2, 2021
4
165
A few "super carriers" with off-the-charts viral loads are likely responsible for the bulk of COVID-19 transmissions, while about half of infected people aren't contagious at all at the time of diagnosis, suggests a new CU ...
Mar 16, 2021
0
710
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing ...
Sep 3, 2013
0
0
South Africa on Wednesday said it was introducing an affordable, cutting-edge drug to fight HIV in the country with the largest number of people living with the AIDS-causing virus.
Nov 27, 2019
0
2
A team of researchers affiliated with multiple institutions in the U.S. and one in the U.K. has found that administering the AstraZeneca COVID-19 vaccine intranasally to infected hamsters and monkeys reduced viral loads in ...
